Jiangsu Hengrui Medicine Co., Ltd (600276.SS) announced a profit for its first quarter that Increased, from the same period last year
The company's earnings totaled RMB2.282 billion, or RMB0.34 per share. This compares with RMB1.874 billion, or RMB0.30 per share, last year.
The company's revenue for the period rose 13.0% to RMB8.140 billion from RMB7.205 billion last year.
Jiangsu Hengrui Medicine Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB2.282 Bln. vs. RMB1.874 Bln. last year.-EPS: RMB0.34 vs. RMB0.30 last year.-Revenue: RMB8.140 Bln vs. RMB7.205 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.